// App-Quantinova.ai

: Myeloproliferative Neoplasms in Patients below 25 Years Old at Diagnosis: A Retrospective International Cooperative Work

Researchers

Presenter

  • Ianotto Jean-Christophe

Principal Investigators

  • Marta Sobas

  • Parvis Sadjadian

  • Lee-Yung Shih

  • Maria Bieniaszewska

  • Ilona Seferynska

  • Mary Frances McMullin

  • Joanna Waclaw

  • Laurence Legros

  • Krzysztof Lewandowski

  • Mihnea Zdrenghea

  • Aitor Abuin Blanco

  • Anna Armatys

  • Jan Samuelsson

  • Adrianna Spalek

  • Anna Angola Figueras

  • Marie Lauermannova

  • Mara-Soledad Noya

  • Jaroslaw Czyz

  • Anna Szmigielska-Kaplon

  • Rajko Kusec

  • Joanna Gora Tybor

  • Anna Masternak

  • Jan J. Michiels

  • Malgorzata Skowronek

  • Jean-Loup Demory

  • Katell Le Du

  • Sonja Zweegman

  • Carlos Besses Raebel

  • Stephane Giraudier

  • Martin Griesshammer

  • Claire N. Harrison

Medical Centers

  • Institute of Oncology and Hematology, Hopital Morvan, CHRU de Brest, Brest, France

  • France Intergroupe des Néoplasies Myéloprolifratives, FIM collaborative group, Paris, France

  • Hospital Saint Antoine, Paris, France

  • Department of Hematology, Wroclaw Medical University, Wroclaw, Poland

  • Polish Adult Leukemia Group, PALG collaborative group, Warsaw, Poland

  • University Clinic for Hematology, Oncology and Palliative Cares, University of Bochum, Minden, Germany

  • Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

  • Department of Hematology and Transplantation, Gdansk Medical University and Clinical Center, Gdansk, Poland

  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa,

  • Queen's University Belfast, Belfast, United Kingdom

  • Department of Hematology, Jagiellonian University Hospital, Krakow, Poland

  • Department of Hematology, Centre Hospitalier Universitaire Caen, Caen, France

  • France Intergroupe des Néoplasies Myéloprolifratives, FIM collaborative group, Paris, France

  • Department of Hematology and Bone Marrow Transplantation, University of Medical Sciences, Poznan, Poland

  • Institute of Oncology, University Hospital of Cluj, Cluj-Napoca, Romania

  • Department of Hematology, Clinical Hospital, Santiago de Compostela, Spain

  • Hematology and Bone Marrow Transplantation , Medical University of Silesia, Katowice, Poland,

  • Department of Hematology,University Hospital Linköping,Linköping,Sweden

  • Department of Hematology, Hospital del Mar, Barcelona, Spain

  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Department of Hematology, Complexo Hospitalario Juan Canalejo, A Coruna, Spain

  • Department of Hematology, Collegium Medicum, Bydgoszcz, Poland

  • Department of Hematology, Medical University of Lodz, Lodz, Poland

  • Hematology, Dubrava University Hospital, Zagreb, Croatia

  • Department of Hematology, State Hospital, Opole, POL

  • Goodheart Institute & Foundation Center Europe, Rotterdam, Netherlands

  • Department of Hematology, Holy Cross Oncology Center, Kielce, Poland

  • Dept. of Hematology, Hopital St. Vincent, Lille, France

  • Department of Hematology, Centre Jean Bernard - Clinique Victor Hugo,Le Mans,France

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Department of Hematology, Hospital del Mar, Barcelona, Spain

  • Service de Biologie Cellulaire, INSERM UMRS 1131, Hospital of Saint-Louis, Paris, France

  • INSERM UMR-S1131, Institut Univeristaire d'Hematologie, Universite Paris-Diderot, Assistance Publique Hopitaux de Paris, Hopital Saint-Louis, Paris, France

  • Department of Hematology, Oncology, Hemostaseology and Palliative Care,Johannes Wesling Clinic,Minden,Germany

  • Department of Virology, Royal Free Hospital, London, United Kingdom

Locations

  • France

  • Poland

  • Germany

  • Taiwan

  • United Kingdom

  • Romania

  • Spain

  • Sweden

  • Czech Republic

  • Croatia

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Polycythemia vera

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

Drug/Treatment

  • Hydroxycarbamide

  • Anagrelide hydrochloride

  • Interferon

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved